BMY vs ZETA · P/E 17, rev $24.46B vs rev $839.1M
Bristol-Myers Squibb Company (BMY) versus Zeta Global Holdings Corp (ZETA) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Zeta Global Holdings Corp (ZETA) is a software - infrastructure company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ZETA revenue for 2026-06-30 was $839.1M. Net income was -$5.1M. ZETA currently screens at market cap $4.50B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ZETA currently screens at market cap $4.50B.
Not investment advice. Open the BMY and ZETA stock pages for the full models.
Not investment advice.